Список литературы

1. Coppola G., Veggiotti P., Cusmai R. et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience. Epilepsy Res. 2002;48(3):221-227. doi:10.1016/s0920-1211(01)00315-1 2. Усачева Е.Л., Айвазян С.О., Сорвачева Т.Н., Пырьева Е.А., Шорина М.Ю. Применение кетогенной диеты в лечении фармакорезистентных эпилепсий. Журнал неврологии и психиатрии им. С.С. Корсакова. 2004; 7:29-34. 3. Сорвачева Т.Н., Пырьева Е.А., Конь И.Я., Усачева Е.Л., Айвазян С.О., Шорина М.Ю. Кетогенная диета в комплексном лечении фармакорезистентных форм эпилепсии у детей: клиническая оценка эффективности. Педиатрия. 2003;2:41-45. 4. Stafstrom C.E. Dietary approaches to epilepsy treatment: old and new options on the menu. Epilepsy Curr. 2004;4(6):215-222. doi:10.1111/j.1535-7597.2004.46001.x 5. National Library of Medicine, Genetics Home Reference your Guide to Understanding Genetic Conditions, GLUT1 deficiency syndrome. 2014. 6. Cheng C.M., Hicks K., Wang J., Eagles D.A., Bondy C.A. Caloric restriction augments brain glutamic acid decarboxylase-65 and -67 expression. J Neurosci Res. 2004;77(2):270-276. doi:10.1002/jnr.20144 7. Coman D.J., Sinclair K.G., Burke C.J., Appleton D.B. et al. Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome. J Paediatr Child Health. 2006 May;42(5):263-7. doi: 10.1111/j.1440-1754.2006.00852.x. 8. Larsen J., Johannesen K.M., Ek J., Tang S. et al. The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome. Epilepsia. 2015 Dec;56(12):e203-8. doi: 10.1111/epi.13222. 9. Ramm-Pettersen A, Nakken KO, Haavardsholm KC, Selmer KK. GLUT1-deficiency syndrome: Report of a four-generation Norwegian family with a mild phenotype. Epilepsy Behav. 2017;70(Pt A):1-4.doi: 10.1016/j.yebeh.2017.02.016 10. Ivanova N, Peycheva V, Kamenarova K, et al. Three novel SLC2A1 mutations in Bulgarian patients with different forms of genetic generalized epilepsy reflecting the clinical and genetic diversity of GLUT1-deficiency syndrome. Seizure. 2018; 54:41-44. doi: 10.1016/j.seizure.2017.11.014 11. Liu Y, Bao X, Wang D, et al. Allelic variations of glut-1 deficiency syndrome: the chinese experience. Pediatr Neurol. 2012;47(1):30-34. doi: 10.1016/j.pediatrneurol.2012.04.010 12. Weber Y.G., Kamm C., Suls A. et al. Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology. 2011;77(10):959-964. doi:10.1212/WNL.0b013e31822e0479 13. Klepper J., Voit T. Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain-- a review. Eur J Pediatr. 2002;161(6):295- 304.doi:10.1007/s00431-002-0939-3 14. Morris A.A. Cerebral ketone body metabolism. J Inherit Metab Dis. 2005;28(2):109-121. doi:10.1007/s10545-005-5518-0 55 15. Chinnery P.F. Defining neurogenetic phenotypes (or how to compare needles in haystacks). Brain.2010;133(Pt3):649-651.doi:10.1093/brain/awq027 16. Leen W.G., Klepper J., Verbeek M.M. et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain. 2010;133(Pt 3):655- 670.doi:10.1093/brain/awp336 17. Yang H., Wang D., Engelstad K. et al. Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol. 2011;70(6):996–1005. doi: 10.1002/ana.22640 18. Wang D., Pascual J.M., De Vivo D. Glucose Transporter Type 1 Deficiency Syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; July 30, 2002 (last update March 3, 2018) 19. Лукьянова Е.Г., Айвазян С.О., Осипова К.В., Пырьева Е.А., Сорвачева Т.Н. Опыт применения кетогенной диеты у пациентов с синдромом дефицита транспортера глюкозы I типа (клиническое наблюдение) / Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2015. — Т. 115(5–2). — С. 53–60. — doi: 10.17116/jnevro20151155253-60. 20. Zorzi G., Castellotti B., Zibordi F., Gellera C., Nardocci N. Paroxysmal movement disorders in GLUT1 deficiency syndrome. Neurology. 2008;71(2):146-148. doi:10.1212/01.wnl.0000316804.10020.ba 21. Urbizu A., Cuenca-León E., Raspall-Chaure M. et al. Paroxysmal exercise-induced dyskinesia, writer's cramp, migraine with aura and absence epilepsy in twin brothers with a novel SLC2A1 missense mutation. J Neurol Sci. 2010;295(1-2):110-113. doi: 10.1016/j.jns.2010.05.017 22. De Vivo D.C., Wang D. Glut1 deficiency: CSF glucose. How low is too low?. Rev Neurol (Paris). 2008;164(11):877-880. doi: 10.1016/j.neurol.2008.10.001 23. Overweg-Plandsoen W.C., Groener J.E., Wang D. et al. GLUT-1 deficiency without epilepsy- -an exceptional case. J Inherit Metab Dis. 2003;26(6):559-563. doi: 10.1023/a:1025999914822 24. Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, Shimizu T, Yudkoff M, Daikhin Y, Nissim I, Lazarow A. Brain amino acid metabolism and ketosis. The Journal of Neuroscience Journal of Neuroscience Research. 2001;66:272-281. 25. Leen W.G., Wevers R.A., Kamsteeg E.J., Scheffer H,. Verbeek MM, Willemsen MA. Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review. JAMA Neurol. 2013;70(11):1440-1444. doi:10.1001/jamaneurol.2013.3090 26. Klepper J, Akman C, Armeno M, et al. Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group. Epilepsia Open. 2020;5(3):354-365. Published 2020 Aug 13. doi:10.1002/epi4.12414 27. Pong AW, Geary BR, Engelstad KM, Natarajan A, Yang H, De Vivo DC. Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes. Epilepsia. 2012;53(9):1503- 1510.doi:10.1111/j.1528-1167.2012.03592.x 28. Wolking S, Becker F, Bast T, et al. Focal epilepsy in glucose transporter type 1 (Glut1) defects: case reports and a review of literature. J Neurol. 2014;261(10):1881-1886. doi:10.1007/s00415-014-7433-5 56 29. Peeraer A, Damiano JA, Bellows ST, et al. Evaluation of GLUT1 variation in non-acquired focal epilepsy. Epilepsy Res. 2017;133:54-57. doi:10.1016/j.eplepsyres.2017.04.007 30. Pearson T.S., Pons R., Engelstad K., Kane S.A., Goldberg M.E., De Vivo D.C. Paroxysmal eye-head movements in Glut1 deficiency syndrome. Neurology. 2017;88(17):1666-1673. doi:10.1212/WNL.0000000000003867. 31. Leary L.D., Wang D., Nordli D.R. Jr, Engelstad K., De Vivo D.C. Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome. Epilepsia. 2003;44(5):701-707.doi:10.1046/j.1528-1157.2003.05302.x 32. Vining E.P., Freeman J.M., Ballaban-Gil K. et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol. 1998;55(11):1433-1437. doi:10.1001/archneur.55.11.1433 33. Усачева Е.Л., Айвазян С.О., Сорвачева Т.Н., Пырьева Е.А., Конь И.Я., Притыко А.Г., Шорина М.Ю., Осипова К.В. Кетогенная диета в лечении фармакорезистентных эпилепсий. Лечащий врач. 2004; 5:46-50. 34. Кетогенная диета в лечении фармакорезистентных эпилепсий: показания к применению, критерии эффективности, осложнения: Методические рекомендации №7, Правительство Москвы, Департамент здравоохранения. М.; 2005;20. 35. Striano P., Weber Y.G., Toliat M.R. et al. GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy. Neurology. 2012;78(8):557-562. doi:10.1212/WNL.0b013e318247ff54 36. Klepper J., Fischbarg J., Vera J.C., Wang D., De Vivo D.C. GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro. Pediatr Res. 1999;46(6):677-683. doi:10.1203/00006450-199912000-00006 37. Pons R., Collins A., Rotstein M., Engelstad K., De Vivo DC. The spectrum of movement disorders in Glut-1 deficiency. Mov Disord. 2010;25(3):275-281. doi:10.1002/mds.22808 38. Pearson T.S., Akman C., Hinton V.J., Engelstad K., De Vivo D.C. Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep. 2013;13(4):342. doi:10.1007/s11910-013-0342-7 39. Alter A.S., Engelstad K., Hinton V.J. et al. Long-term clinical course of Glut1 deficiency syndrome. J Child Neurol. 2015;30(2):160-169. doi:10.1177/0883073814531822 40. Hully M, Vuillaumier-Barrot S, Le Bizec C, et al. From splitting GLUT1 deficiency syndromes to overlapping phenotypes. Eur J Med Genet. 2015;58(9):443-454. doi: 10.1016/j.ejmg.2015.06.007 41. Brockmann K. The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev. 2009;31(7):545-552. doi: 10.1016/j.braindev.2009.02.008 42. Ito Y, Takahashi S, Kagitani-Shimono K, et al. Nationwide survey of glucose transporter-1 deficiency syndrome (GLUT-1DS) in Japan. Brain Dev. 2015;37(8):780-789. doi: 10.1016/j.braindev.2014.11.006 43. Willemsen MA, Vissers LE, Verbeek MM, et al. Upstream SLC2A1 translation initiation causes GLUT1 deficiency syndrome. Eur J Hum Genet. 2017;25(6):771-774. doi:10.1038/ejhg.2017.45 57 44. Friedman JR, Thiele EA, Wang D, et al. Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet. Mov Disord. 2006;21(2):241-245. doi:10.1002/mds.20660 45. Ebrahimi-Fakhari D., Pearl P.L. Movement disorders and inherited metabolic disorders – recognition, understanding, improving outcomes. – Cambridge University Press. – 2020. – 442 p. 46. Leen WG, Taher M, Verbeek MM, Kamsteeg EJ, van de Warrenburg BP, Willemsen MA. GLUT1 deficiency syndrome into adulthood: a follow-up study. J Neurol. 2014;261(3): 589- 599.doi:10.1007/s00415-014-7240-z 47. Pérez-Dueñas B., Prior C., Ma Q. et al. Childhood chorea with cerebral hypotrophy: a treatable GLUT1 energy failure syndrome. Arch Neurol. 2009;66(11):1410-1414. doi: 10.1001/archneurol.2009.236 48. Suls A., Dedeken P., Goffin K. et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain. 2008;131(Pt 7):1831-1844.doi:10.1093/brain/awn113 49. Weber Y.G., Storch A., Wuttke T.V. et al. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest. 2008;118(6):2157-2168. doi:10.1172/JCI34438. 50. Айвазян С.О., Лукьянова Е.Г., Ширяев Ю.С. Немедикаментозные методы лечения фармакорезистентной эпилепсии у детей. Эпилепсия и пароксизмальные состояния. 2014;6:1:34–43. 51. Pascual J.M., Wang D., Yang R., Shi L., Yang H., De Vivo D.C. Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutants. J Biol Chem. 2008;283(24):16732–16742. doi: 10.1074/jbc.M801403200 52. Wang D., Yang H., Shi L. et al. Functional studies of the T295M mutation causing Glut1 deficiency: glucose efflux preferentially affected by T295M. Pediatr Res. 2008;64(5):538- 543.doi:10.1203/PDR.0b013e318184d2b5 53. Klepper J., Scheffer H., Leiendecker B. et al. Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively. Neuropediatrics. 2005;36(5):302-308. doi:10.1055/s-2005-872843 54. Wang D., Pascual J.M., Yang H. et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol. 2005;57(1):111–118. doi: 10.1002/ana.20331 55. De Vivo D.C., Bohan T.P., Coulter D.L. et al. L-carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia. 1998;39(11):1216–1225. doi: 10.1111/j.1528- 1157.1998.tb01315.x 56. De Vivo D.C., Trifiletti R.R., Jacobson R.I., Ronen G.M., Behmand R.A., Harik S.I. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med. 1991;325(10):703–709. doi: 10.1056/NEJM199109053251006 57. Pike M. Opsoclonus-myoclonus syndrome. Handb Clin Neurol. 2013;112:1209–1211. doi: 10.1016/B978-0-444-52910-7.00042-8 58 58. Тутельян В.А., Батурин А.К., Гаппаров М.Б. и др. Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации. 2009; МР 2.3.1.2432-08.-40с. 59. Wang D., Ho Y-Y, Pascual J.M., Hinton V. et al. GLUT1 deficiency syndrome: R333W genotype and paternal mosaicism. Ann Neurol. 2001;50:S124. 60. Klepper J., Scheffer H., Elsaid M.F., Kamsteeg E.J. et al. Autosomal recessive inheritance of GLUT1 deficiency syndrome. Neuropediatrics. 2009;40(5):207-210. doi:10.1055/s-0030- 1248264 61. Rotstein M., Engelstad K., Yang H. et al. Glut1 deficiency: inheritance pattern determined by haploinsufficiency. Ann Neurol. 2010;68(6):955-958. doi:10.1002/ana.22088 62. Freeman J., Veggiotti P., Lanzi G., Tagliabue A., Perucca E. The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Research. 2006; 68: 145-180. doi: 10.1016/j.eplepsyres.2005.10.003. 63. Roubergue A., Apartis E., Mesnage V. et al. Dystonic tremor caused by mutation of the glucose transporter gene GLUT1. J Inherit Metab Dis. 2011;34(2):483-488. doi:10.1007/s10545-010-9264-6 64. Pascual JM, Ronen GM. Glucose Transporter Type I Deficiency (G1D) at 25 (1990-2015): Presumptions, Facts, and the Lives of Persons With This Rare Disease. Pediatr Neurol. 2015;53(5):379-393.doi:10.1016/j.pediatrneurol.2015.08.001 65. Кожанова Т.В., Жилина С.С., Мещерякова Т.И., Айвазян С.О., Осипова К.В., Сушко Л.М., Лукьянова Е.Г., Притыко А.Г. Синдром дефицита транспортера глюкозы I типа (болезнь де Виво): клинические и генетические аспекты. Медицинская генетика. 2016;15(7):28-32.https://doi.org/10.1234/XXXX-XXXX-2016-7-28-32 66. Shibata T, Kobayashi K, Yoshinaga H, Ono H, Shinpo M, Kagitani-Shimono K. Another Case of Glucose Transporter 1 Deficiency Syndrome with Periventricular Calcification, Cataracts, Hemolysis, and Pseudohyperkalemia. Neuropediatrics. 2017;48(5):390-393. doi:10.1055/s0037-1603520 67. Lukyanova E.G., Sushko L.M., Ayvazyan S.O. , Osipova K.V. , Pyreva E.A., Sorvacheva T.N., Zhilina S.S., Kozhanova T.V., Mescheryakova T.I. Glucose Transporter Type 1 Deficiency Syndrome (GLUT1) and using Ketogenic Diet in Treatment of De Vivo Disease: A Case Reports. Glob J Intellect Dev Disabil 2(3) 2017: 71-77. 68. Mullen SA, Suls A, De Jonghe P, Berkovic SF, Scheffer IE. Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology. 2010;75(5):432- 440.doi:10.1212/WNL.0b013e3181eb58b4 69. Kossoff E.H., Zupec-Kania B.A., Auvin S. et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;3(2):175-192. Published 2018 May 21. doi:10.1002/epi4.12225 70. Van der Louw E, van den Hurk D, Neal E, et al. Ketogenic diet guidelines for infants with refractory epilepsy. Eur J Paediatr Neurol. 2016;20(6):798-809. doi: 10.1016/j.ejpn.2016.07.009 71. Klepper J., Leiendecker B., Kossoff E.H. Pocket guide to the ketogenic diet. SPS publications, 54 p 59 72. Zupec-Kania B., Vanatta L., Johnson M. Ketogenic diet therapies for neurological disorders pocket guide for medical professionals. The Charlie foundation for ketogenic therapies 2018. 73. Vaudano A.E., Olivotto S., Ruggieri A. et al. Brain correlates of spike and wave discharges in GLUT1 deficiency syndrome. Neuroimage Clin. 2016;13:446-454. Published 2016 Dec 21. doi:10.1016/j.nicl.2016.12.026 74. Ismayilova N, Hacohen Y, MacKinnon AD, Elmslie F, Clarke A. GLUT-1 deficiency presenting with seizures and reversible leukoencephalopathy on MRI imaging. Eur J Paediatr Neurol.2018;22(6):1161-1164.doi:10.1016/j.ejpn.2018.02.002 75. Zeng W., Xing Z., Tan M. et al. Propofol regulates activated macrophages metabolism through inhibition of ROS-mediated GLUT1 expression. Inflamm. Res. 70, 473–481 (2021). doi: 10.1007/s00011-021-01449-y 76. Schiller K., Avigdor T., Kortas A., Kunz M. et al. Monitoring Glucose Concentrations in Children with Epilepsy on a Ketogenic Diet. Healthcare (Basel). 2022 Jan 27;10(2):245. doi: 10.3390/healthcare10020245 77. Ketogenic diet — managing complications, version 1. Cambridge University Hospitals NHS Foundation Trust, 12 p 78. Baumeister FA, Oberhoffer R, Liebhaber GM, et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics. 2004;35(4):250-252. doi:10.1055/s-2004- 820992 79. Yudkoff M., Daikhin Y., Nissim I., Lazarow A., Nissim I. Brain amino acid metabolism and ketosis. J Neurosci Res. 2001;66(2):272-281. doi:10.1002/jnr.1221 80. Akman C.I., Provenzano F., Wang D. et al. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency. Epilepsy Res. 2015;110:206-215. doi: 10.1016/j.eplepsyres.2014.11.007 81. Ruiz Herrero J., Cañedo Villarroya E., González Gutiérrez-Solana L. et al. Classic Ketogenic Diet and Modified Atkins Diet in SLC2A1 Positive and Negative Patients with Suspected GLUT1 Deficiency Syndrome: A Single Center Analysis of 18 Cases. Nutrients. 2021 Mar 4;13(3):840. doi: 10.3390/nu13030840. 82. Butte NF, Watson KB, Ridley K, et al. A Youth Compendium of Physical Activities: Activity Codes and Metabolic Intensities. Med Sci Sports Exerc. 2018;50(2):246-256. doi:10.1249/MSS.0000000000001430 83. Daci A, Bozalija A, Jashari F, Krasniqi S. Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency. Int J Mol Sci. 2018;19(1):122. Published 2018 Jan 5. doi:10.3390/ijms19010122 84. Adeva-Andany MM, Fernández-Fernández C, Mouriño-Bayolo D, Castro-Quintela E, Domínguez-Montero A. Sodium bicarbonate therapy in patients with metabolic acidosis. ScientificWorldJournal. 2014;2014:627673. doi:10.1155/2014/627673 85. Gras D, Roze E, Caillet S, Méneret A, Doummar D, Billette de Villemeur T, Vidailhet M, Mochel F. GLUT1 deficiency syndrome: an update. Rev Neurol (Paris). 2014 Feb;170(2):91- 9. doi: 10.1016/j.neurol.2013.09.005. 86. Ho Y.Y., Yang H, Klepper J, Fischbarg J. et al. Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro. Pediatr Res. 2001;50(2):254-260. doi:10.1203/00006450-200108000-00015 60 87. Brockmann K., Wang D., Korenke C.G. et al. Autosomal dominant glut-1 deficiency syndrome and familial epilepsy. Ann Neurol. 2001;50(4):476–485. doi: 10.1002/ana.1222